Nestec S.a.

Beth Israel Deaconess Medical Center, Inc.

Julie Moulin

Frederic Destaillats

Fabiola Dionisi

Cristina Cruz-Hernandez

Isabelle Masserey-Elmelegy

Manuel Oliveira

Bruce R Bistrian

Olivier Aprikian

Katherine Mace

Theresa Voss

Yasaman Shahkhalili

Kevin Acheson

Irene Zbinden

The present invention generally relates to the field of nutrition. In particular the present invention relates to infant nutrition in the post natal period and in early life, more particular during the age period of 6-36 months or during a part thereof. One embodiment of the present invention is a kit of diet compositions for children during the age period of 6-36 months or during a part thereof, wherein the macronutrient content of the compositions is gradually changing in the form of a straight line from a composition that comprises about 40-50% energy from fat and about 40-49% energy from carbohydrates for children at the age of 6 months to a composition that comprises about 30-35% energy from fat and about 50-55% energy from carbohydrates for children at the age of 36 months, and its use to prevent obesity later in life.

Metabolic imprinting

The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising a sn-2 monoacylglycerol derivative, wherein the sn-1 and sn-3 positions are blocked by protective groups. The acyl group may be a fatty acid, for example one with anti-inflammatory properties.

Sn-2-monoacylglycerols and lipid malabsorption

Sn-2-monoacylgycerols and lipid malabsorption

The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising sn-1(3) monoacylglycerols, wherein the sn-1 or sn-3 position is occupied by an acyl group such as a fatty acid and the sn-2 position remains unoccupied. The fatty acid may be one with anti-inflammatory properties.

Sn-1(3) monoacylglycerides and lipid absorption

Growing community of inventors

Attalens, Switzerland

Julie Moulin